Magazine

A legacy-driven media platform documenting Korean excellence in culture, economy, and identity

Legacy & Pioneer

July 14, 2025

Dr. Steve Kwon, Holy Name Cancer Surgeon: "Cancer Can Be Overcome with Personalized Treatment and Patient Determination"

The Leading Cause of Death Among Adults

Cancer: The Most Feared Disease

Cancer, historically considered incurable, now boasts significantly higher survival rates due to advancements in medical technology. At the forefront of this progress is surgical intervention, playing a pivotal role in cancer treatment. A collaboration among specialists in diverse medical fields underscores the potential to overcome cancer through personalized treatment and patient determination.

Photo credits: Mom&i

By Kim Hee-jun - Reporter at Mom&i

Interview with Dr. Steve Kwon - Holynaim Cancer Surgeon

Q: It’s a pleasure to meet you. Why did you choose surgical oncology out of all the medical fields?

A:
Hello, I'm Steve Kwon, a newly appointed specialist in cancer surgery at the Holynaim Medical Center. There's significant potential for tailored treatment for Korean cancer patients here in New Jersey, which excites me greatly. My interest in surgical oncology was sparked during a surgical mission when I encountered the power of surgery firsthand. Witnessing critical patients' recovery inspired me to make a difference.

Q: Could you outline the path to becoming a surgical oncologist? What key qualities are necessary?

A:
The essential components are continuous "practical training" and "dedication." I trained in general surgery at Washington State University, selecting it for its extensive hands-on program. Unlike many, my training included varied experiences across university, county, and private hospitals, ensuring extensive real-world surgical exposure. Prompt judgment and response are vital, as surgical oncology often involves life-threatening situations. Observing and learning from other surgeons were also instrumental in my growth.

Q: With your experience in major surgeries, are there any moments that particularly stand out?

A:
I recall a liver cancer patient, where significant blood loss during surgery led to an unavoidable loss, despite our best efforts. Such experiences, although heartbreaking, offer profound lessons. It’s rewarding to see patients improve after recovery from poor conditions.

Q: Cancer cases seem more prevalent today, yet treatment appears easier compared to the past. Is that accurate?

A:
Early diagnosis and prevention are crucial. Epidemiological studies show a marked shift in Korea's leading causes of death, with cancer rising from 11% in the 1980s to 28% in 2010. Korean men frequently battle stomach, lung, liver, and colorectal cancers, while women face stomach, breast, colorectal, and cervical cancers. Although Korea has high gastric and liver cancer rates, the mortality rate remains comparatively low due to early detection and experienced medical professionals. Developing cancer diagnosis programs tailored to Korean patients is an ongoing priority.

Q: What medically matters most in cancer treatment?

A:
Cancer treatment's interdisciplinary nature is unique, necessitating collective efforts from medical experts. Internal medicine oncologists manage chemotherapy, while radiation oncologists handle radiation treatments, introducing varied innovative techniques like stereotactic body radiotherapy. As a surgical oncologist, my role involves tumor excision. Collaboration among specialists, including pathologists for biopsy assessments, is indispensable. Joint planning and case reviews ensure comprehensive care, positioning cancer treatment as a cooperative endeavor rather than a solitary effort.

Q: All cancer stages from one to four are known. Are all patients at the same stage equally at risk?

A:
Not necessarily. Innovations in personalized cancer treatment highlight the individual differences in responses due to genetic variations. Continuous dialogue and tailored treatment strategies are essential, as responses vary. Adjusting treatments or surgeries according to patient status is vital for optimized care.

Q: Breast cancer is said to be self-detectable. Can other cancers also be self-monitored?

A:
Unlike breast cancer, early detection of other types is challenging without structured programs. Participating in preventive programs established for various age groups is crucial. At Holynaim Hospital, we offer systematic screenings, including hepatitis and ultrasound tests, to identify cancers early on.

Q: Any parting words for cancer patients and their families?

A:
A memorable line from the "Lord of the Rings" film resonates with me: "There is always hope!" Some may feel despondent upon diagnosis, but I assure you, recovery is within reach. Countless support systems and advancing treatments provide many pathways to triumph over illness.

Dr. Steve Kwon - Cancer Specialist

Credentials of Dr. Steve Kwon

  • University of Illinois College of Medicine
  • MPH in Epidemiology from University of Washington Medical Center
  • Residency at University of Washington Medical Center
  • Surgical Oncology at Memorial Sloan Kettering Cancer Center

Holynaim Hospital's Cancer Specialty Center
For appointments and inquiries: 201-833-3399